August 4th, 2010
Research Suggests Possible New Early Strategies for HCM
Sanjay Kaul, MD
CardioExchange welcomes Carolyn Ho to discuss her study in the New England Journal of Medicine, which looked at myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy (HCM). Her team found that levels of serum C-terminal propeptide of type I procollagen (PICP) were higher in mutation carriers without LVH and in patients with HCM than […]
July 20th, 2010
Who Should Treat Advanced HF/Transplant Patients?
Larry Husten, PHD
The ACC, AHA, and several other organizations have released the first Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant. “The current statement describes the level of experience, knowledge, and technical skills necessary for competent performance in caring for these complex patients,” write the authors of the report, including the chair […]
July 16th, 2010
FDA reviewing link between ARBs and cancer
Larry Husten, PHD
The FDA issued a safety communication and stated that it was conducting a review of ARBs and cancer.
July 15th, 2010
Heart Failure Society of America
CardioExchange Editors, Staff
Heart Failure Society of America 15th Annual Scientific Meeting Boston, MA
July 15th, 2010
Heart Failure Society of America
Larry Husten, PHD
Boston, MA 15th Annual Scientific Meeting
July 15th, 2010
Heart Failure Society of America
Larry Husten, PHD
San Diego, CA 14th Annual Scientific Meeting
June 3rd, 2010
What are the Dangers of Shorter Hospital Stays for HF Patients?
Héctor Bueno, MD, PhD
CardioExchange welcomes Dr. Héctor Bueno to answer questions about his recent paper in JAMA, which found that shorter hospital stays for heart-failure patients have resulted in fewer deaths in the hospital, but at the cost of more readmissions, leading researchers to speculate that “because length of stay has substantially decreased, improvement is less than what might […]
May 27th, 2010
The Tests Say Intervene, but the Patient Feels Fine
Anju Nohria, MD and James Fang, MD
A 58-year-old asymptomatic man with hypertension and hyperlipidemia was noted to have an abnormal electrocardiogram during his routine annual physical examination. His primary care physician ordered a treadmill stress test. The patient exercised for 6 minutes and 39 seconds of a standard Bruce protocol, achieving 8.1 METs. He stopped because of dyspnea. His heart rate increased […]
March 31st, 2010
Her Cancer Treatment Is Working, but Her Heart Is Failing
Anju Nohria, MD and James Fang, MD
The patient is a 57-year-old woman with a history of Hodgkin disease of the anterior mediastinum. Upon being diagnosed at age 26, she was treated with a staging laparotomy, splenectomy, and 36 Gy of radiation to the mantle and para-aortic areas. She did well until September 2009, when she developed increasing dyspnea on exertion, weight […]
March 26th, 2010
Hospital Volume and Outcomes: Size Matters, but Only to a Point
Joseph S. Ross, MD, MHS
This week we welcome CardioExchange Contributor Joseph Ross, MD, to answer questions about his study in NEJM, Hospital Volume and 30 Day Mortality for Three Common Medical Conditions (co-authored with CardioExchange Editor, Harlan Krumholz, MD). CardioExchange Editors: What does this research add to our current knowledge about volume and outcomes? The relationship between greater volume […]
NEJM Journal Watch — Recent Cardiology Articles- To Lower Stroke Risk in Patients Undergoing Atrial Fibrillation Ablation, Is a Device or a Medication Better?
- Intensive vs. Standard Blood Pressure Lowering in Patients with Diabetes
- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy